Capecitabine, Cisplatin, and Trastuzumab

About

Membership operator: AND

Therapies: 3

Therapies

Capecitabine (tx:ncit:C1794)

Cisplatin (tx:ncit:C376)

Trastuzumab (tx:ncit:C1647)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
EMA (1) HER2-positive Esophagogastric Adenocarcinoma Capecitabine, Cisplatin, Trastuzumab
EMA (1) ERBB2 amplification Esophagogastric Adenocarcinoma Capecitabine, Cisplatin, Trastuzumab